COVID 19 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • mRNA-1273.351
  • Decatur, Georgia
  • +3 more
2021-12-02
Dec 2, 2021
N
Recruiting
  • COVID-19
  • ChAdV68-S
  • +4 more
  • Decatur, Georgia
  • +4 more
2021-12-02
Dec 2, 2021
A
Recruiting
  • COVID-19
  • +2 more
  • Vibrolung
  • Astana, Kazakhstan
  • +2 more
2021-11-22
Nov 22, 2021
O
Completed
  • COVID-19
  • Sars-CoV-2 Infection
    • Gravedona, Como, Italy
      "Moriggia Pelascini" Hospital
    2021-12-02
    Dec 2, 2021
    N
    Not yet recruiting
    • COVID-19
      • Bethesda, Maryland
      • +1 more
      2021-12-02
      Dec 2, 2021
      J
      Recruiting
      • COVID-19
      • DANA app
      • Baltimore, Maryland
        Johns Hopkins Psychiatry department
      2021-12-01
      Dec 1, 2021
      E
      Recruiting
      • COVID-19
      • +2 more
      • Fitbit
      • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2021-12-02
      Dec 2, 2021
      V
      Recruiting
      • COVID-19
      • Rehabilitation-focused program
      • Seattle, Washington
        VA Puget Sound Health Care System Seattle Division, Seattle, WA
      2021-12-02
      Dec 2, 2021
      W
      Withdrawn
      • SARS-CoV-2
      • Covid-19
      • Sirolimus 1 MG/ML
      • Placebo
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      2021-12-02
      Dec 2, 2021
      T
      Completed
      • COVID-19
      • Boston, Massachusetts
        Tufts Medical Center
      2021-12-01
      Dec 1, 2021
      N
      Active, not recruiting
      • COVID-19
      • COVID-19 Immunisation
      • mRNA-1273
      • Decatur, Georgia
      • +2 more
      2021-12-02
      Dec 2, 2021
      S
      Completed
      • COVID-19
      • Pneumonia, Viral
      • Lung Ultrasound
      • San Francisco, California
      • +1 more
      2021-12-02
      Dec 2, 2021
      U
      Completed
      • COVID-19
      • High-titer Convalescent COVID-19 Plasma (CCP1)
      • Standard-titer Convalescent COVID-19 plasma (CCP2)
      • Chapel Hill, North Carolina
        University of North Carolina Health Care
      2021-12-01
      Dec 1, 2021
      J
      Completed
      • COVID-19
      • SARS-CoV-2 convalescent plasma
      • Danderyd, Stockholm, Sweden
      • +1 more
      2021-12-02
      Dec 2, 2021
      N
      Not yet recruiting
      • COVID-19
      • Obesity
        • Phoenix, Arizona
          NIDDK, Phoenix
        2021-12-02
        Dec 2, 2021
        N
        Recruiting
        • Anogenital Herpes
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2021-12-02
          Dec 2, 2021
          H
          Recruiting
          • COVID-19
          • SARS-CoV-2 Acute Respiratory Disease
          • COVID-19 Vaccine HIPRA
          • Cominarty (Pfizer-BioNtech)
          • Hanoi, Vietnam
            National Institute of Hygiene and Epidemiology
          2021-12-01
          Dec 1, 2021
          C
          Not yet recruiting
          • COVID-19
          • Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)
          • Placebo
          • (no location specified)
          2021-11-19
          Nov 19, 2021
          F
          Not yet recruiting
          • Chronic Kidney Diseases
          • +2 more
          • Blood samples
          • Amadora, Portugal
          • +3 more
          2021-12-01
          Dec 1, 2021
          T
          Recruiting
          • COVID-19
          • Homologous mRNA booster vaccine
          • +4 more
          • Singapore, Singapore
            National Centre for Infectious Diseases (NCID)
          2021-11-30
          Nov 30, 2021